Outcomes of Antiretroviral Therapy in the Swiss HIV Cohort Study: Latent Class Analysis

被引:0
|
作者
Olivia Keiser
Ben Spycher
Andri Rauch
Alexandra Calmy
Matthias Cavassini
Tracy R. Glass
Dunja Nicca
Bruno Ledergerber
Matthias Egger
机构
[1] University of Bern,Institute of Social and Preventive Medicine (ISPM)
[2] Bern University Hospital and University of Bern,University Clinic for Infectious Diseases
[3] University Hospital Geneva,Division of Infectious Diseases
[4] University Hospital Lausanne,Division of Infectious Diseases
[5] University Hospital Basel,Basel Institute for Clinical Epidemiology and Biostatistics
[6] Cantonal Hospital St.Gallen,Division of Infectious Diseases
[7] University Hospital,Division of Infectious Diseases and Hospital Epidemiology
[8] University of Zürich,undefined
来源
AIDS and Behavior | 2012年 / 16卷
关键词
HIV infection; Antiretroviral therapy; Disease progression; Mortality; Social factors; Behavior; Latent class analysis;
D O I
暂无
中图分类号
学科分类号
摘要
An in-depth understanding of the different groups that make up the HIV-infected population should inform prevention and care. Using latent class analysis (LCA) we identified seven groups with similar socio-demographic and behavioral characteristics at enrolment in the Swiss HIV Cohort Study: older gay men, younger gay men, older heterosexual men, injection drug users, single migrants, migrant women in partnerships and heterosexual men and women. Outcomes of combination antiretroviral therapy (ART) were analyzed in 1,633 patients starting ART. Compared to older gay men, the probability of a virologic response to ART was reduced in single migrants, in older heterosexual men and in IDUs. Loss to follow-up was higher in single migrants and IDUs, and mortality was increased in older heterosexual men and IDUs. Socio-behavioral groups identified by LCA allow insights above what can be gleaned from traditional transmission groups, and may identify patients who could benefit from targeted interventions.
引用
收藏
页码:245 / 255
页数:10
相关论文
共 50 条
  • [21] Response to first protease inhibitor- and efavirenz-containing antiretroviral combination therapy - The Swiss HIV Cohort Study
    Friedl, AC
    Ledergerber, B
    Flepp, M
    Hirschel, B
    Telenti, A
    Furrer, H
    Bucher, HC
    Bernasconi, E
    Weber, R
    AIDS, 2001, 15 (14) : 1793 - 1800
  • [22] Hepatitis B Virus Infection Is Associated With Impaired Immunological Recovery During Antiretroviral Therapy in the Swiss HIV Cohort Study
    Wandeler, Gilles
    Gsponer, Thomas
    Bihl, Florian
    Bernasconi, Enos
    Cavassini, Matthias
    Kovari, Helen
    Schmid, Patrick
    Battegay, Manuel
    Calmy, Alexandra
    Egger, Matthias
    Furrer, Hansjakob
    Rauch, Andri
    JOURNAL OF INFECTIOUS DISEASES, 2013, 208 (09): : 1454 - 1458
  • [23] Self-reported alcohol consumption and its association with adherence and outcome of antiretroviral therapy in the Swiss HIV Cohort Study
    Conen, Anna
    Fehr, Jan
    Glass, Tracy R.
    Furrer, Hansjakob
    Weber, Rainer
    Vernazza, Pietro
    Hirschel, Bernard
    Cavassini, Matthias
    Bernasconil, Enos
    Bucher, Heiner C.
    Battegay, Manuel
    ANTIVIRAL THERAPY, 2009, 14 (03) : 349 - 357
  • [24] Uniform risk of clinical progression despite differences in utilization of highly active antiretroviral therapy: Swiss HIV Cohort Study
    Junghans, C
    Low, N
    Chan, P
    Witschi, A
    Vernazza, P
    Egger, M
    AIDS, 1999, 13 (18) : 2547 - 2554
  • [25] Associations Between Antiretroviral Treatment and Avascular Bone Necrosis: The Swiss HIV Cohort Study
    Bayard, Cornelia
    Ledergerber, Bruno
    Flepp, Markus
    Lecompte, Thanh
    Moulin, Estelle
    Hoffmann, Matthias
    Weber, Rainer
    Staehelin, Cornelia
    Di Benedetto, Caroline
    Fux, Christoph A.
    Tarr, Philip E.
    Hasse, Barbara
    OPEN FORUM INFECTIOUS DISEASES, 2017, 4 (04):
  • [26] Association of Alcohol Consumption and HIV Surrogate Markers in Participants of the Swiss HIV Cohort Study
    Conen, Anna
    Wang, Qing
    Glass, Tracy R.
    Fux, Christoph A.
    Thurnheer, Maria C.
    Orasch, Christina
    Calmy, Alexandra
    Bernasconi, Enos
    Vernazza, Pietro
    Weber, Rainer
    Bucher, Heiner C.
    Battegay, Manuel
    Fehr, Jan
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2013, 64 (05) : 472 - 478
  • [27] Obesity Trends and Body Mass Index Changes After Starting Antiretroviral Treatment: The Swiss HIV Cohort Study
    Hasse, Barbara
    Iff, Martin
    Ledergerber, Bruno
    Calmy, Alexandra
    Schmid, Patrick
    Hauser, Christoph
    Cavassini, Matthias
    Bernasconi, Enos
    Marzolini, Catia
    Tarr, Philip E.
    OPEN FORUM INFECTIOUS DISEASES, 2014, 1 (02):
  • [28] Systemic delays in the initiation of antiretroviral therapy during pregnancy do not improve outcomes of HIV-positive mothers: a cohort study
    Myer, Landon
    Zulliger, Rose
    Bekker, Linda-Gail
    Abrams, Elaine
    BMC PREGNANCY AND CHILDBIRTH, 2012, 12
  • [29] Migrants from Sub-Saharan Africa in the Swiss HIV Cohort Study: access to antiretroviral therapy, disease progression and survival
    Staehelin, C
    Rickenbach, M
    Low, N
    Egger, M
    Ledergerber, B
    Hirschel, B
    D'Acremont, V
    Battegay, M
    Wagels, T
    Bernasconi, E
    Kopp, C
    Furrer, H
    AIDS, 2003, 17 (15) : 2237 - 2244
  • [30] Insurability of HIV-positive people treated with antiretroviral therapy in Europe: collaborative analysis of HIV cohort studies
    Kaulich-Bartz, Josee
    Dam, Wayne
    May, Margaret T.
    Lederberger, Bruno
    Widmer, Urs
    Phillips, Andrew N.
    Grabar, Sophie
    Mocroft, Amanda
    Vilaro, Josep
    van Sighem, Ard
    Moreno, Santiago
    Dabis, Francois
    Monforte, Antonella D'Arminio
    Teira, Ramon
    Ingle, Suzanne M.
    Sterne, Jonathan A. C.
    AIDS, 2013, 27 (10) : 1641 - 1655